Shandong Sito Bio-technology Co., Ltd. (SHE:300583)

SHE:300583 Revenue

Shandong Sito Bio-technology had revenue of 257.31M CNY in the quarter ending September 30, 2026, with 6.58% growth. This brings the company's total for the last twelve months to 1.14B, up 19.16% year-over-year. In the year 2025, Shandong Sito Bio-technology had annual revenue of 1.02B with 4.77% growth. That makes Shandong Sito Bio-technology the 18,649th largest company in the world by revenue and 3,415th in China.

• Revenue (ttm): 1.14B
• Revenue Growth: +19.16%
• P/S Ratio: 1.90
• Revenue / Employee: 1.15M
• Employees: 990
• Market Cap: 2.14B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing 973.52M 95.7%
• Unallocated Other 43.35M 4.3%

By Geography

Chart

• China 946.84M 93.1%
• Overseas 70.03M 6.9%

Fiscal year ended Dec 31, 2025 See the full SHE:300583 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.02B	46.27M	4.77%
Dec 31, 2024	970.60M	-309.18M	-24.16%
Dec 31, 2023	1.28B	-32.33M	-2.46%
Jan 1, 2023	1.31B	109.49M	9.10%
Jan 1, 2022	1.20B	289.44M	31.70%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error